{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T09:52:52Z","timestamp":1773827572080,"version":"3.50.1"},"reference-count":133,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","surgpath.theclinics.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Pathology Clinics"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.path.2015.10.003","type":"journal-article","created":{"date-parts":[[2016,3,2]],"date-time":"2016-03-02T01:34:05Z","timestamp":1456882445000},"page":"55-77","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["B-cell Lymphoproliferative Disorders Associated with Primary and Acquired Immunodeficiency"],"prefix":"10.1016","volume":"9","author":[{"given":"Lawrence K.","family":"Low","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joo Y.","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.path.2015.10.003_bib1","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1146\/annurev-pathol-012513-104656","article-title":"Gammaherpesviruses and lymphoproliferative disorders","volume":"9","author":"Cesarman","year":"2014","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.path.2015.10.003_bib2","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"Swerdlow","year":"2008"},{"key":"10.1016\/j.path.2015.10.003_bib3","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.blre.2008.03.009","article-title":"Immunodeficiency-associated lymphomas","volume":"22","author":"Tran","year":"2008","journal-title":"Blood Rev"},{"key":"10.1016\/j.path.2015.10.003_bib4","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.semcancer.2013.08.004","article-title":"Lymphomas occurring specifically in HIV-infected patients: from pathogenesis to pathology","volume":"23","author":"Gloghini","year":"2013","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.path.2015.10.003_bib5","doi-asserted-by":"crossref","first-page":"e132","DOI":"10.1038\/emm.2014.82","article-title":"EBV-driven B-cell lymphoproliferative disorders: from biology, classification and differential diagnosis to clinical management","volume":"47","author":"Ok","year":"2015","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.path.2015.10.003_bib6","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0046-8177(97)90137-4","article-title":"AIDS-related primary brain lymphomas: histopathologic and immunohistochemical study of 51 cases. The French Study Group for HIV-Associated Tumors","volume":"28","author":"Camilleri-Broet","year":"1997","journal-title":"Hum Pathol"},{"key":"10.1016\/j.path.2015.10.003_bib7","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJM199305063281806","article-title":"Brief report: reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis","volume":"328","author":"Kamel","year":"1993","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.path.2015.10.003_bib8","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1200\/JCO.1996.14.6.1943","article-title":"Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases","volume":"14","author":"Salloum","year":"1996","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.path.2015.10.003_bib9","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1002\/art.20311","article-title":"Lymphoma in rheumatoid arthritis: the effect of methotrexate and anti-tumor necrosis factor therapy in 18,572 patients","volume":"50","author":"Wolfe","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.path.2015.10.003_bib10","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1002\/art.22579","article-title":"The effect of methotrexate and anti-tumor necrosis factor therapy on the risk of lymphoma in rheumatoid arthritis in 19,562 patients during 89,710 person-years of observation","volume":"56","author":"Wolfe","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.path.2015.10.003_bib11","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1182\/blood-2013-11-536433","article-title":"Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue","volume":"123","author":"Scott","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.path.2015.10.003_bib12","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","article-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray","volume":"103","author":"Hans","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.path.2015.10.003_bib13","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling","volume":"403","author":"Alizadeh","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.path.2015.10.003_bib14","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.3324\/haematol.2009.016113","article-title":"Aggressive large B-cell lymphoma with plasma cell differentiation: immunohistochemical characterization of plasmablastic lymphoma and diffuse large B-cell lymphoma with partial plasmablastic phenotype","volume":"95","author":"Montes-Moreno","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.path.2015.10.003_bib15","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.1182\/blood-2002-10-3090","article-title":"Gene expression profile analysis of AIDS-related primary effusion lymphoma (PEL) suggests a plasmablastic derivation and identifies PEL-specific transcripts","volume":"101","author":"Klein","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.path.2015.10.003_bib16","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1182\/blood-2002-10-3161","article-title":"Gene expression profiling of plasma cells and plasmablasts: toward a better understanding of the late stages of B-cell differentiation","volume":"102","author":"Tarte","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.path.2015.10.003_bib17","doi-asserted-by":"crossref","first-page":"4852","DOI":"10.1182\/blood-2010-10-310995","article-title":"A20 (TNFAIP3) genetic alterations in EBV-associated AIDS-related lymphoma","volume":"117","author":"Giulino","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.path.2015.10.003_bib18","doi-asserted-by":"crossref","first-page":"360","DOI":"10.5858\/arpa.2012-0095-RA","article-title":"Lymphoid proliferations associated with human immunodeficiency virus infection","volume":"137","author":"Chadburn","year":"2013","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.path.2015.10.003_bib19","doi-asserted-by":"crossref","first-page":"e121","DOI":"10.1016\/j.clml.2014.12.010","article-title":"Case report and review of immunodeficiency-associated Burkitt lymphoma","volume":"15","author":"Johnson","year":"2015","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.path.2015.10.003_bib20","doi-asserted-by":"crossref","first-page":"8477","DOI":"10.1200\/JCO.2005.02.9355","article-title":"Prognostic factors in HIV-related diffuse large-cell lymphoma: before versus after highly active antiretroviral therapy","volume":"23","author":"Lim","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.path.2015.10.003_bib21","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/10428190400015733","article-title":"Changing incidence and prognostic factors of survival in AIDS-related non-Hodgkin's lymphoma in the era of highly active antiretroviral therapy (HAART)","volume":"46","author":"Wolf","year":"2005","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.path.2015.10.003_bib22","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1634\/theoncologist.11-4-375","article-title":"Burkitt's lymphoma: clinicopathologic features and differential diagnosis","volume":"11","author":"Ferry","year":"2006","journal-title":"Oncologist"},{"key":"10.1016\/j.path.2015.10.003_bib23","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1634\/theoncologist.2008-0036","article-title":"EBV-associated lymphoproliferative disorders: classification and treatment","volume":"13","author":"Carbone","year":"2008","journal-title":"Oncologist"},{"key":"10.1016\/j.path.2015.10.003_bib24","doi-asserted-by":"crossref","first-page":"3788","DOI":"10.1200\/JCO.1998.16.12.3788","article-title":"Burkitt-like lymphomas in AIDS patients: characterization within a series of 103 human immunodeficiency virus-associated non-Hodgkin's lymphomas. Burkitt's Lymphoma Study Group","volume":"16","author":"Davi","year":"1998","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.path.2015.10.003_bib25","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/path.2410","article-title":"MYC translocation-negative classical Burkitt lymphoma cases: an alternative pathogenetic mechanism involving miRNA deregulation","volume":"216","author":"Leucci","year":"2008","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.path.2015.10.003_bib26","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nature11378","article-title":"Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics","volume":"490","author":"Schmitz","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.path.2015.10.003_bib27","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/bjh.13221","article-title":"Survival of AIDS-related diffuse large B-cell lymphoma, Burkitt lymphoma, and plasmablastic lymphoma in the German HIV Lymphoma Cohort","volume":"168","author":"Schommers","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1016\/j.path.2015.10.003_bib28","doi-asserted-by":"crossref","first-page":"735392","DOI":"10.1155\/2012\/735392","article-title":"HIV-associated burkitt lymphoma: good efficacy and tolerance of intensive chemotherapy including CODOX-M\/IVAC with or without RItuximab in the HAART Era","volume":"2012","author":"Rodrigo","year":"2012","journal-title":"Adv Hematol"},{"key":"10.1016\/j.path.2015.10.003_bib29","doi-asserted-by":"crossref","first-page":"403648","DOI":"10.1155\/2012\/403648","article-title":"Paradigms and controversies in the treatment of HIV-related burkitt lymphoma","volume":"2012","author":"Petrich","year":"2012","journal-title":"Adv Hematol"},{"key":"10.1016\/j.path.2015.10.003_bib30","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1089\/apc.2007.0124","article-title":"Improving outcomes for patients with Burkitt lymphoma and HIV","volume":"22","author":"Blinder","year":"2008","journal-title":"AIDS Patient Care STDS"},{"key":"10.1016\/j.path.2015.10.003_bib31","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1158\/1055-9965.EPI-13-0865","article-title":"Prevalence of HIV Infection among U.S. Hodgkin lymphoma cases","volume":"23","author":"Shiels","year":"2014","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.path.2015.10.003_bib32","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1097\/QAD.0000000000000428","article-title":"Risk of non-Hodgkin lymphoma subtypes in HIV-infected people during the HAART era: a population-based study","volume":"28","author":"Gibson","year":"2014","journal-title":"AIDS"},{"key":"10.1016\/j.path.2015.10.003_bib33","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1089\/apc.2012.0424","article-title":"Clinical characteristics, incidence, and risk factors of HIV-related Hodgkin lymphoma in the era of combination antiretroviral therapy","volume":"27","author":"Gotti","year":"2013","journal-title":"AIDS Patient Care STDS"},{"key":"10.1016\/j.path.2015.10.003_bib34","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/S0959-8049(01)00122-8","article-title":"Clinical aspects and management of Hodgkin's disease and other tumours in HIV-infected individuals","volume":"37","author":"Vaccher","year":"2001","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.path.2015.10.003_bib35","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1200\/JCO.1995.13.7.1758","article-title":"Hodgkin's disease and human immunodeficiency virus infection: clinicopathologic and virologic features of 114 patients from the Italian Cooperative Group on AIDS and Tumors","volume":"13","author":"Tirelli","year":"1995","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.path.2015.10.003_bib36","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0889-8588(03)00046-7","article-title":"Hodgkin's disease in HIV","volume":"17","author":"Spina","year":"2003","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.path.2015.10.003_bib37","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/PAP.0b013e31805048fc","article-title":"Immunodeficiency-related Hodgkin lymphoma and its mimics","volume":"14","author":"Said","year":"2007","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.path.2015.10.003_bib38","first-page":"2319","article-title":"Human immunodeficiency virus-associated Hodgkin's disease derives from post-germinal center B cells","volume":"93","author":"Carbone","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.path.2015.10.003_bib39","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s11899-014-0215-4","article-title":"Managing HIV and Hodgkin lymphoma in the twenty-first century","volume":"9","author":"Aries","year":"2014","journal-title":"Curr Hematol Malig Rep"},{"key":"10.1016\/j.path.2015.10.003_bib40","doi-asserted-by":"crossref","first-page":"507257","DOI":"10.1155\/2012\/507257","article-title":"HIV-associated hodgkin's lymphoma: prognosis and therapy in the era of cART","volume":"2012","author":"Jacobson","year":"2012","journal-title":"Adv Hematol"},{"key":"10.1016\/j.path.2015.10.003_bib41","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0046-8177(72)80005-4","article-title":"Lymphomatoid granulomatosis","volume":"3","author":"Liebow","year":"1972","journal-title":"Hum Pathol"},{"key":"10.1016\/j.path.2015.10.003_bib42","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/PAS.0000000000000328","article-title":"Lymphomatoid granulomatosis\u2013a single institute experience: pathologic findings and clinical correlations","volume":"39","author":"Song","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2015.10.003_bib43","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/1097-0142(197901)43:1<360::AID-CNCR2820430151>3.0.CO;2-8","article-title":"Lymphomatoid granulomatosis: a clinicopathologic study of 152 cases","volume":"43","author":"Katzenstein","year":"1979","journal-title":"Cancer"},{"key":"10.1016\/j.path.2015.10.003_bib44","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1097\/00000478-199408000-00001","article-title":"Pulmonary lymphomatoid granulomatosis. Evidence for a proliferation of Epstein-Barr virus infected B-lymphocytes with a prominent T-cell component and vasculitis","volume":"18","author":"Guinee","year":"1994","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2015.10.003_bib45","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.1182\/blood.V87.11.4531.bloodjournal87114531","article-title":"Association of lymphomatoid granulomatosis with Epstein-Barr viral infection of B lymphocytes and response to interferon-alpha 2b","volume":"87","author":"Wilson","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.path.2015.10.003_bib46","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3109\/00313028609059478","article-title":"Lymphomatoid granulomatosis: a clinicopathologic study of 42 patients","volume":"18","author":"Koss","year":"1986","journal-title":"Pathology"},{"key":"10.1016\/j.path.2015.10.003_bib47","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1182\/blood-2009-11-253039","article-title":"The role of tumor histogenesis, FDG-PET, and short-course EPOCH with dose-dense rituximab (SC-EPOCH-RR) in HIV-associated diffuse large B-cell lymphoma","volume":"115","author":"Dunleavy","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.path.2015.10.003_bib48","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/PAS.0b013e3181cf8622","article-title":"EBV positive mucocutaneous ulcer\u2013a study of 26 cases associated with various sources of immunosuppression","volume":"34","author":"Dojcinov","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2015.10.003_bib49","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1097\/PAS.0000000000000282","article-title":"EBV-positive mucocutaneous ulcer in organ transplant recipients: a localized indolent posttransplant lymphoproliferative disorder","volume":"38","author":"Hart","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2015.10.003_bib50","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s00428-011-1064-3","article-title":"Iatrogenic EBV-positive lymphoproliferative disorder with features of EBV+ mucocutaneous ulcer: evidence for concomitant TCRgamma\/IGH rearrangements in the Hodgkin-like neoplastic cells","volume":"458","author":"Di Napoli","year":"2011","journal-title":"Virchows Arch"},{"key":"10.1016\/j.path.2015.10.003_bib51","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1093\/annonc\/mdp064","article-title":"Epstein-Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8-9 September 2008","volume":"20","author":"Cohen","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1016\/j.path.2015.10.003_bib52","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1182\/blood.V89.4.1413","article-title":"Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection","volume":"89","author":"Delecluse","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.path.2015.10.003_bib53","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1182\/blood-2014-10-567479","article-title":"The biology and treatment of plasmablastic lymphoma","volume":"125","author":"Castillo","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.path.2015.10.003_bib54","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1097\/01.pas.0000126781.87158.e3","article-title":"Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities","volume":"28","author":"Colomo","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2015.10.003_bib55","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1097\/PAS.0000000000000234","article-title":"Clinicopathologic comparison of plasmablastic lymphoma in HIV-positive, immunocompetent, and posttransplant patients: single-center series of 25 cases and meta-analysis of 277 reported cases","volume":"38","author":"Morscio","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2015.10.003_bib56","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1093\/annonc\/mdh399","article-title":"CD20-negative large-cell lymphoma with plasmablastic features: a clinically heterogenous spectrum in both HIV-positive and -negative patients","volume":"15","author":"Teruya-Feldstein","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1016\/j.path.2015.10.003_bib57","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/modpathol.3800355","article-title":"Plasmablastic lymphomas and plasmablastic plasma cell myelomas have nearly identical immunophenotypic profiles","volume":"18","author":"Vega","year":"2005","journal-title":"Mod Pathol"},{"key":"10.1016\/j.path.2015.10.003_bib58","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1309\/AJCPFUR1BK0UODTS","article-title":"Plasmablastic lymphomas with MYC\/IgH rearrangement: report of three cases and review of the literature","volume":"132","author":"Bogusz","year":"2009","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.path.2015.10.003_bib59","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1097\/PAS.0b013e3181f3e29f","article-title":"IG\/MYC rearrangements are the main cytogenetic alteration in plasmablastic lymphomas","volume":"34","author":"Valera","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2015.10.003_bib60","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1756-8722-2-47","article-title":"Genomic profiling of plasmablastic lymphoma using array comparative genomic hybridization (aCGH): revealing significant overlapping genomic lesions with diffuse large B-cell lymphoma","volume":"2","author":"Chang","year":"2009","journal-title":"J\u00a0Hematol Oncol"},{"key":"10.1016\/j.path.2015.10.003_bib61","series-title":"Pathology and genetics: tumours of haematopoietic and lymphoid tissues","author":"Jaffe","year":"2001"},{"key":"10.1016\/j.path.2015.10.003_bib62","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1182\/blood.V88.2.645.bloodjournal882645","article-title":"Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus","volume":"88","author":"Nador","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.path.2015.10.003_bib63","doi-asserted-by":"crossref","first-page":"3124","DOI":"10.1182\/blood.V88.8.3124.bloodjournal8883124","article-title":"Primary effusion lymphoma in women: report of two cases of Kaposi's sarcoma herpes virus-associated effusion-based lymphoma in human immunodeficiency virus-negative women","volume":"88","author":"Said","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.path.2015.10.003_bib64","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/cncr.23597","article-title":"PEL and HHV8-unrelated effusion lymphomas: classification and diagnosis","volume":"114","author":"Carbone","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.path.2015.10.003_bib65","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.5858\/arpa.2012-0294-RS","article-title":"Primary effusion lymphoma","volume":"137","author":"Patel","year":"2013","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.path.2015.10.003_bib66","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1182\/blood.V96.9.3279","article-title":"Molecular evidence of organ-related transmission of Kaposi sarcoma-associated herpesvirus or human herpesvirus-8 in transplant patients","volume":"96","author":"Luppi","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.path.2015.10.003_bib67","first-page":"1637","article-title":"Expression of human herpesvirus-8 oncogene and cytokine homologues in an HIV-seronegative patient with multicentric Castleman's disease and primary effusion lymphoma","volume":"78","author":"Teruya-Feldstein","year":"1998","journal-title":"Lab Invest"},{"key":"10.1016\/j.path.2015.10.003_bib68","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1097\/01.pas.0000138177.10829.5c","article-title":"KSHV-positive solid lymphomas represent an extra-cavitary variant of primary effusion lymphoma","volume":"28","author":"Chadburn","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2015.10.003_bib69","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1182\/blood-2004-05-1798","article-title":"KSHV viral cyclin binds to p27KIP1 in primary effusion lymphomas","volume":"104","author":"Jarviluoma","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.path.2015.10.003_bib70","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S1525-1578(10)60004-9","article-title":"Kaposi's sarcoma-associated herpesvirus\/human herpesvirus type 8-positive solid lymphomas: a tissue-based variant of primary effusion lymphoma","volume":"7","author":"Carbone","year":"2005","journal-title":"J\u00a0Mol Diagn"},{"key":"10.1016\/j.path.2015.10.003_bib71","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1182\/blood-2007-05-092288","article-title":"The viral interferon-regulatory factor-3 is required for the survival of KSHV-infected primary effusion lymphoma cells","volume":"111","author":"Wies","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.path.2015.10.003_bib72","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1084\/jem.20031467","article-title":"KSHV vFLIP is essential for the survival of infected lymphoma cells","volume":"199","author":"Guasparri","year":"2004","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.path.2015.10.003_bib73","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/47266","article-title":"p53 inhibition by the LANA protein of KSHV protects against cell death","volume":"402","author":"Friborg","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.path.2015.10.003_bib74","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/80459","article-title":"The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene Hras transforms primary rat cells","volume":"6","author":"Radkov","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.path.2015.10.003_bib75","doi-asserted-by":"crossref","first-page":"11698","DOI":"10.1128\/JVI.06855-11","article-title":"A\u00a0Kaposi's sarcoma-associated herpesvirus microRNA and its variants target the transforming growth factor beta pathway to promote cell survival","volume":"86","author":"Lei","year":"2012","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.path.2015.10.003_bib76","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/cncr.22691","article-title":"Primary effusion lymphoma: a series of 4 cases and review of the literature with emphasis on cytomorphologic and immunocytochemical differential diagnosis","volume":"111","author":"Brimo","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.path.2015.10.003_bib77","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1182\/blood.V73.3.792.bloodjournal733792","article-title":"Molecular genetic analysis of three AIDS-associated neoplasms of uncertain lineage demonstrates their B-cell derivation and the possible pathogenetic role of the Epstein-Barr virus","volume":"73","author":"Knowles","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.path.2015.10.003_bib78","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/sj.leu.2401651","article-title":"Molecular profile of Epstein-Barr virus infection in HHV-8-positive primary effusion lymphoma","volume":"14","author":"Fassone","year":"2000","journal-title":"Leukemia"},{"key":"10.1016\/j.path.2015.10.003_bib79","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/S0002-9440(10)65749-5","article-title":"Immunoglobulin VH gene mutational analysis suggests that primary effusion lymphomas derive from different stages of B cell maturation","volume":"153","author":"Matolcsy","year":"1998","journal-title":"Am J Pathol"},{"key":"10.1016\/j.path.2015.10.003_bib80","doi-asserted-by":"crossref","first-page":"257","DOI":"10.5858\/1999-123-0257-HIIPEL","article-title":"Herpesvirus 8 inclusions in primary effusion lymphoma: report of a unique case with T-cell phenotype","volume":"123","author":"Said","year":"1999","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.path.2015.10.003_bib81","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00109-003-0519-7","article-title":"Manipulation of glycogen-synthase kinase-3 activity in KSHV-associated cancers","volume":"82","author":"Fujimuro","year":"2004","journal-title":"J\u00a0Mol Med (Berl)"},{"key":"10.1016\/j.path.2015.10.003_bib82","doi-asserted-by":"crossref","first-page":"4193","DOI":"10.1128\/JVI.71.6.4193-4198.1997","article-title":"The cyclin encoded by Kaposi's sarcoma-associated herpesvirus stimulates cdk6 to phosphorylate the retinoblastoma protein and histone H1","volume":"71","author":"Godden-Kent","year":"1997","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.path.2015.10.003_bib83","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1093\/emboj\/18.3.644","article-title":"Degradation of p27(Kip) cdk inhibitor triggered by Kaposi's sarcoma virus cyclin-cdk6 complex","volume":"18","author":"Ellis","year":"1999","journal-title":"EMBO J"},{"key":"10.1016\/j.path.2015.10.003_bib84","doi-asserted-by":"crossref","first-page":"5738","DOI":"10.1038\/sj.onc.1202976","article-title":"Modulation of the NF-kappa B pathway by virally encoded death effector domains-containing proteins","volume":"18","author":"Chaudhary","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.path.2015.10.003_bib85","doi-asserted-by":"crossref","first-page":"9399","DOI":"10.1073\/pnas.0308016101","article-title":"Activation of alternative NF-kappa B pathway by human herpes virus 8-encoded Fas-associated death domain-like IL-1 beta-converting enzyme inhibitory protein (vFLIP)","volume":"101","author":"Matta","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.path.2015.10.003_bib86","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1089\/108729104322802498","article-title":"Failure to eradicate AIDS-associated primary effusion lymphoma with high-dose chemotherapy and autologous stem cell reinfusion: case report and literature review","volume":"18","author":"Waddington","year":"2004","journal-title":"AIDS Patient Care STDS"},{"key":"10.1016\/j.path.2015.10.003_bib87","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1097\/QAD.0b013e3282fc732b","article-title":"Treatment of primary effusion lymphoma with highly active antiviral therapy in the setting of HIV infection","volume":"22","author":"Ripamonti","year":"2008","journal-title":"AIDS"},{"key":"10.1016\/j.path.2015.10.003_bib88","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1182\/blood.V95.4.1406.004k26_1406_1412","article-title":"HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma","volume":"95","author":"Dupin","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.path.2015.10.003_bib89","series-title":"Atlas of lymph node pathology","author":"Miranda","year":"2013"},{"key":"10.1016\/j.path.2015.10.003_bib90","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/CCO.0b013e328355e0f3","article-title":"Recent advances in Kaposi sarcoma herpesvirus-associated multicentric Castleman disease","volume":"24","author":"Uldrick","year":"2012","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.path.2015.10.003_bib91","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1182\/blood.V99.7.2331","article-title":"High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease","volume":"99","author":"Oksenhendler","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.path.2015.10.003_bib92","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1053\/j.seminoncol.2014.12.027","article-title":"Kaposi sarcoma-associated herpesvirus-associated malignancies: epidemiology, pathogenesis, and advances in treatment","volume":"42","author":"Bhutani","year":"2015","journal-title":"Semin Oncol"},{"key":"10.1016\/j.path.2015.10.003_bib93","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1098\/rstb.2000.0778","article-title":"Epidemiology and pathogenesis of Kaposi's sarcoma-associated herpesvirus","volume":"356","author":"Boshoff","year":"2001","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"10.1016\/j.path.2015.10.003_bib94","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1097\/PAS.0b013e3180dc92c4","article-title":"HHV8 in plasmablastic lymphoma","volume":"32","author":"Goedhals","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2015.10.003_bib95","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1097\/PAS.0b013e31804d43d8","article-title":"HHV-8+, EBV+ multicentric plasmablastic microlymphoma in an HIV+ Man: the spectrum of HHV-8+ lymphoproliferative disorders expands","volume":"31","author":"Seliem","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2015.10.003_bib96","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/j.1600-0463.2007.apm_631.x","article-title":"Plasmablastic microlymphoma occurring in human herpesvirus 8 (HHV-8)-positive multicentric Castleman's disease and featuring a follicular growth pattern","volume":"115","author":"Dargent","year":"2007","journal-title":"APMIS"},{"key":"10.1016\/j.path.2015.10.003_bib97","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1309\/AJCPULI3W6WUGGPY","article-title":"Diverse clinicopathologic features in human herpesvirus 8-associated lymphomas lead to diagnostic problems","volume":"142","author":"Courville","year":"2014","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.path.2015.10.003_bib98","first-page":"207","article-title":"What Is the best treatment for HIV-associated multicentric Castleman disease?","volume":"10","author":"Bower","year":"2012","journal-title":"Clin Adv Hematol Oncol"},{"key":"10.1016\/j.path.2015.10.003_bib99","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s11899-013-0162-5","article-title":"Post-transplant lymphoproliferative disease (PTLD): risk factors, diagnosis, and current treatment strategies","volume":"8","author":"Al-Mansour","year":"2013","journal-title":"Curr Hematol Malig Rep"},{"key":"10.1016\/j.path.2015.10.003_bib100","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1136\/bmj.4.5633.746","article-title":"Reticulum cell sarcoma after renal homotransplantation and azathioprine and prednisone therapy","volume":"4","author":"Doak","year":"1968","journal-title":"Br Med J"},{"key":"10.1016\/j.path.2015.10.003_bib101","first-page":"106","article-title":"Malignant lymphomas in transplantation patients","volume":"1","author":"Penn","year":"1969","journal-title":"Transplant Proc"},{"key":"10.1016\/j.path.2015.10.003_bib102","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1034\/j.1399-3062.2001.003002070.x","article-title":"Identifying the patient at risk for post-transplant lymphoproliferative disorder","volume":"3","author":"Cockfield","year":"2001","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.path.2015.10.003_bib103","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/hon.859","article-title":"Genetic and phenotypic analysis of B-cell post-transplant lymphoproliferative disorders provides insights into disease biology","volume":"26","author":"Vakiani","year":"2008","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.path.2015.10.003_bib104","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.critrevonc.2005.03.015","article-title":"Post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantation","volume":"56","author":"Taylor","year":"2005","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.path.2015.10.003_bib105","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1365-2141.2010.08161.x","article-title":"Diagnosis of post-transplant lymphoproliferative disorder in solid organ transplant recipients - BCSH and BTS Guidelines","volume":"149","author":"Parker","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1016\/j.path.2015.10.003_bib106","first-page":"1059","article-title":"The role of\u00a0HLA mismatch, splenectomy and recipient Epstein-Barr virus seronegativity as risk factors in post-transplant lymphoproliferative disorder following allogeneic hematopoietic stem cell transplantation","volume":"91","author":"Sundin","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.path.2015.10.003_bib107","doi-asserted-by":"crossref","first-page":"669","DOI":"10.3109\/0284186X.2013.844853","article-title":"A\u00a0population-based study of 135 lymphomas after solid organ transplantation: the role of Epstein-Barr virus, hepatitis C and diffuse large B-cell lymphoma subtype in clinical presentation and survival","volume":"53","author":"Kinch","year":"2014","journal-title":"Acta Oncol"},{"key":"10.1016\/j.path.2015.10.003_bib108","first-page":"431","article-title":"Post-transplant lymphoproliferative disorders after solid organ transplantation in children","volume":"107","author":"Colita","year":"2012","journal-title":"Chirurgia (Bucur)"},{"key":"10.1016\/j.path.2015.10.003_bib109","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1046\/j.1600-6143.2003.00325.x","article-title":"Lymphomas after solid organ transplantation: a collaborative transplant study report","volume":"4","author":"Opelz","year":"2004","journal-title":"Am J Transplant"},{"issue":"Suppl 1","key":"10.1016\/j.path.2015.10.003_bib110","doi-asserted-by":"crossref","first-page":"S402","DOI":"10.1111\/j.1432-2277.2000.tb02070.x","article-title":"Lymphoproliferative disorders in heart transplant recipients: role of hepatitis C virus (HCV) and Epstein-Barr virus (EBV) infection","volume":"13","author":"Buda","year":"2000","journal-title":"Transpl Int"},{"key":"10.1016\/j.path.2015.10.003_bib111","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1086\/514142","article-title":"Posttransplant lymphoproliferative disease in primary Epstein-Barr virus infection after liver transplantation: the role of cytomegalovirus disease","volume":"176","author":"Manez","year":"1997","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.path.2015.10.003_bib112","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.transproceed.2007.02.037","article-title":"Seroprevalence of human herpes virus-8 in renal transplant recipients: a single center study from Iran","volume":"39","author":"Ahmadpoor","year":"2007","journal-title":"Transplant Proc"},{"key":"10.1016\/j.path.2015.10.003_bib113","doi-asserted-by":"crossref","first-page":"4992","DOI":"10.1182\/blood-2008-09-178046","article-title":"Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation","volume":"113","author":"Landgren","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.path.2015.10.003_bib114","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1034\/j.1399-3062.2001.003002088.x","article-title":"The diverse pathology of post-transplant lymphoproliferative disorders: the importance of a standardized approach","volume":"3","author":"Nalesnik","year":"2001","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.path.2015.10.003_bib115","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1200\/JCO.2012.43.2344","article-title":"Post-transplantation lymphoproliferative disorder after kidney transplantation: report of a nationwide French registry and the development of a new prognostic score","volume":"31","author":"Caillard","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.path.2015.10.003_bib116","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1200\/JCO.2009.25.4961","article-title":"Multicenter analysis of 80 solid organ transplantation recipients with post-transplantation lymphoproliferative disease: outcomes and prognostic factors in the modern era","volume":"28","author":"Evens","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.path.2015.10.003_bib117","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1182\/blood-2014-11-599951","article-title":"The tumor virus landscape of AIDS-related lymphomas","volume":"125","author":"Arvey","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.path.2015.10.003_bib118","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/ajh.21903","article-title":"Malignancies in the setting of primary immunodeficiency: implications for hematologists\/oncologists","volume":"86","author":"Shapiro","year":"2011","journal-title":"Am J Hematol"},{"key":"10.1016\/j.path.2015.10.003_bib119","first-page":"162","article-title":"Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency","volume":"5","author":"Al-Herz","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.path.2015.10.003_bib120","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1007\/s10875-013-9951-9","article-title":"Clinical, immunological, and molecular characterization of hyper-IgM syndrome due to CD40 deficiency in eleven patients","volume":"33","author":"Al-Saud","year":"2013","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.path.2015.10.003_bib121","doi-asserted-by":"crossref","first-page":"6288","DOI":"10.1182\/blood-2008-12-115253","article-title":"Recent advances in understanding the pathophysiology of Wiskott-Aldrich syndrome","volume":"113","author":"Bosticardo","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.path.2015.10.003_bib122","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1182\/blood-2011-09-377945","article-title":"Morbidity and mortality in common variable immune deficiency over 4 decades","volume":"119","author":"Resnick","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.path.2015.10.003_bib123","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.jaci.2011.03.052","article-title":"Morbidity and mortality from ataxia-telangiectasia are associated with ATM genotype","volume":"128","author":"Micol","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.path.2015.10.003_bib124","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/path.2418","article-title":"Unique morphological spectrum of lymphomas in Nijmegen breakage syndrome (NBS) patients with high frequency of consecutive lymphoma formation","volume":"216","author":"Gladkowska-Dura","year":"2008","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.path.2015.10.003_bib125","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1182\/blood-2010-06-284935","article-title":"X-linked lymphoproliferative disease due to SAP\/SH2D1A deficiency: a multicenter study on the manifestations, management and outcome of the disease","volume":"117","author":"Booth","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.path.2015.10.003_bib126","doi-asserted-by":"crossref","first-page":"4798","DOI":"10.1182\/blood-2011-04-347641","article-title":"A\u00a0survey of 90 patients with autoimmune lymphoproliferative syndrome related to TNFRSF6 mutation","volume":"118","author":"Neven","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.path.2015.10.003_bib127","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/BF00917330","article-title":"Chronic active Epstein-Barr virus infection in patients with Chediak-Higashi syndrome","volume":"6","author":"Merino","year":"1986","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.path.2015.10.003_bib128","first-page":"1476","article-title":"TNF and chronic B lymphoproliferative disorders","volume":"7","author":"Heslop","year":"1993","journal-title":"Leukemia"},{"key":"10.1016\/j.path.2015.10.003_bib129","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1097\/MEG.0b013e32834bb90a","article-title":"Hepatosplenic T-cell lymphoma in patients receiving TNF-alpha inhibitor therapy: expanding the groups at risk","volume":"23","author":"Parakkal","year":"2011","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.path.2015.10.003_bib130","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1038\/ajg.2011.283","article-title":"Role of thiopurine and anti-TNF therapy in lymphoma in inflammatory bowel disease","volume":"106","author":"Herrinton","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.path.2015.10.003_bib131","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1136\/ard.2009.117762","article-title":"Lymphoma in patients treated with anti-TNF: results of the 3-year prospective French RATIO registry","volume":"69","author":"Mariette","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.path.2015.10.003_bib132","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1053\/j.gastro.2013.07.035","article-title":"Risk of lymphoma in patients with ulcerative colitis treated with thiopurines: a nationwide retrospective cohort study","volume":"145","author":"Khan","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.path.2015.10.003_bib133","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/S0140-6736(09)61302-7","article-title":"Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study","volume":"374","author":"Beaugerie","year":"2009","journal-title":"Lancet"}],"container-title":["Surgical Pathology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918115001191?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918115001191?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,5]],"date-time":"2022-06-05T23:55:43Z","timestamp":1654473343000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875918115001191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":133,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S1875918115001191"],"URL":"https:\/\/doi.org\/10.1016\/j.path.2015.10.003","relation":{},"ISSN":["1875-9181"],"issn-type":[{"value":"1875-9181","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"B-cell Lymphoproliferative Disorders Associated with Primary and Acquired Immunodeficiency","name":"articletitle","label":"Article Title"},{"value":"Surgical Pathology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.path.2015.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}